Bisphosphonates modulate the effect of macrophage-like cells on osteoblast

被引:13
作者
Evans, CE [1 ]
机构
[1] Univ Manchester, Lab Med Acad Grp, Manchester M13 9PT, Lancs, England
关键词
bisphosphonates; osteoblast and macrophages; cell culture;
D O I
10.1016/S1357-2725(01)00147-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Macrophages (MPs) are present in many tissues and have been implicated in the excessive bone resorption seen in patients with skeletal disorders. Our previous studies showed that macrophage-like cells influenced osteoblasts (OB) in co-culture. as number and activity of osteoblasts were decreased in co-cultures compared with controls. Macrophages ire probable precursors of osteoblasts which have been shown to be inhibited by bisphosphonates (BPs). Bisphosphonates also modulate macrophage and osteoblasts activity. This study investigated whether addition of bisphosphonates to co-cultures of osteoblast and macrophages could reduce or block the adverse effect of macrophages on osteoblasts. The results showed that, compared to controls, fewer osteoblasts were present overtime in macrophage/osteoblast co-cultures (at day 12.15.5 x 10(4) and 8.8 x 10(4). P < 0.0001) and that addition of bisphosphonates ( 10(-9)-10(-5) M) to the co-cultures prevented this reduction ( P < 0.001). Bisphosphonates also elicited an increase in numbers of osteoblast (82%) and restored alkaline phosphatase (ALP) activity, which was reduced by 15% (P congruent to 0.05) compared to control levels. The number of macrophages in co-cultures was reduced when bisphosphonates were added ( P < 0.001) and release of lactate dehydrogenase (LDH) was seen, which was not detectable in control cultures. It therefore. appears that bisphosphonates initiated macrophage death. These results demonstrated that the inhibitory effect of macrophages on osteoblasts in vitro could be overcome by the action of bisphosphonates. These findings have implications for the treatment of skeletal conditions where macrophage-derived cytokines are important. Such as arthritis and implant loosening, although it is clearly important to distinguish between those bisphosphonates which enhance synthesis of pro-inflammatory cytokines and those which inhibit such synthesis. (C) 2002 Elsevier Science Ltd, All rights reserved.
引用
收藏
页码:554 / 563
页数:10
相关论文
共 66 条
[1]  
BATAILLE R, 1995, NEW ENGL J MED, V334, P295
[2]   Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma [J].
Berenson, JR ;
Lichtenstein, A ;
Porter, L ;
Dimopoulos, MA ;
Bordoni, R ;
George, S ;
Lipton, A ;
Keller, A ;
Ballester, O ;
Kovacs, MJ ;
Blacklock, HA ;
Bell, R ;
Simeone, J ;
Reitsma, DJ ;
Heffernan, M ;
Seaman, J ;
Knight, RD .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (08) :488-493
[3]   PRODUCTION OF OSTEOCALCIN BY HUMAN-BONE CELLS-INVITRO - EFFECTS OF 1,25(OH)2D3, 24,25(OH)2D3, PARATHYROID-HORMONE, AND GLUCOCORTICOIDS [J].
BERESFORD, JN ;
GALLAGHER, JA ;
POSER, JW ;
RUSSELL, RGG .
METABOLIC BONE DISEASE & RELATED RESEARCH, 1984, 5 (05) :229-234
[4]   BISPHOSPHONATES DIRECTLY INHIBIT THE BONE-RESORPTION ACTIVITY OF ISOLATED AVIAN OSTEOCLASTS INVITRO [J].
CARANO, A ;
TEITELBAUM, SL ;
KONSEK, JD ;
SCHLESINGER, PH ;
BLAIR, HC .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (02) :456-461
[5]  
CECCHINI MG, 1990, J BONE MINER RES, V5, P1019
[6]  
CECCHINI MG, 1987, J BONE MINER RES, V2, P135
[7]   DIPHOSPHONATES INHIBIT BONE-RESORPTION BY MACROPHAGES INVITRO [J].
CHAMBERS, TJ .
JOURNAL OF PATHOLOGY, 1980, 132 (03) :255-262
[8]   PHAGOCYTIC DEFECTS - MONOCYTES MACROPHAGES [J].
DOUGLAS, SD ;
MUSSON, RA .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1986, 40 (01) :62-68
[9]   Enhancement by galactosamine of lipopolysaccharide(LPS)-induced tumour necrosis factor production and lethality: its suppression by LPS pretreatment [J].
Endo, Y ;
Shibazaki, M ;
Yamaguchi, K ;
Kai, K ;
Sugawara, S ;
Takada, H ;
Kikuchi, H ;
Kumagai, K .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 128 (01) :5-12
[10]   EFFECTS OF 2 NOVEL BISPHOSPHONATES ON BONE-CELLS IN-VITRO [J].
EVANS, CE ;
BRAIDMAN, IP .
BONE AND MINERAL, 1994, 26 (02) :95-107